4
Clinical Trials associated with UCMSC therapy(Ivy Institute of Stem Cells) / Unknown statusPhase 1/2IIT Safety and Efficacy of Human Umbilical-Cord-Derived Mesenchymal Stem Cell Transplantation in Acute Lung Injury
Phase I-II Clinical Trial - Safety and efficacy of umbilical-cord-derived mesenchymal stem cell (UC-MSC) in patients with Acute Lung Injury ,open label, controlled prospective study.
/ Unknown statusPhase 1/2IIT Safety and Efficacy of Human Umbilical-Cord-derived Mesenchymal Stem Cell Transplantation in Active Ulcerative Colitis.
Phase I-II Clinical Trial - Safety and efficacy of umbilical-cord-derived mesenchymal stem cell (UC-MSC) in patients with active ulcerative colitis,randomized, single blind, controlled prospective study.
/ Unknown statusPhase 1/2IIT Safety and Efficacy of Human Umbilical-Cord-derived Mesenchymal Stem Cell Transplantation in Paraquat Poisoning Induced Lung Injury
Phase I-II Clinical Trial-Safety and efficacy of umbilical-cord-derived mesenchymal stem cell (UC-MSC) in patients with paraquat poisoning induced lung injury, randomized,single blind, controlled prospective study.
100 Clinical Results associated with UCMSC therapy(Ivy Institute of Stem Cells)
100 Translational Medicine associated with UCMSC therapy(Ivy Institute of Stem Cells)
100 Patents (Medical) associated with UCMSC therapy(Ivy Institute of Stem Cells)
100 Deals associated with UCMSC therapy(Ivy Institute of Stem Cells)